Medicine
Linagliptin and Metformin 2.5 mg/1000 mg tablet
Linagliptin and Metformin 2.5 mg/1000 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Linagliptin and Metformin
- Brand
- Sold under the generic name
- Strength
- 2.5 mg/1000 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets, 180 tablets
- Manufacturer
- Novadoz PharmaceuticalsIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from exposure to high humidity.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BD11 Linagliptin and Metformin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 November 2025
- Identifiers
- RxCUI 1243020, 1243027, 1243034DailyMed set ID 5cff87ef-97f9-4e3c-9e06-fd257f3cb3fbNDC 72205-409Application ANDA208459
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 72205-409-01 | Novadoz PharmaceuticalsIndia | 4 November 2025 |
| 180 tablet, film coated in 1 bottle | 72205-409-02 | Novadoz PharmaceuticalsIndia | 4 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Linagliptin and Metformin 2.5 mg/1000 mg tablet.
Other strengths and forms of Linagliptin and Metformin
Clinical summary
Linagliptin and Metformin is a fixed-dose combination of a biguanide and a dipeptidyl peptidase 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. MedsAcross supplies Linagliptin and Metformin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Linagliptin and MetforminFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Jentadueto prescribing information (Boehringer Ingelheim Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Jentadueto: European public assessment report (EPAR) · European Medicines Agency
Need Linagliptin and Metformin 2.5 mg/1000 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.